|Articles|June 22, 2009
FDA's Keith Webber on Setting Specifications
Author(s)BioPharm International Editors
Advertisement
FDA´s Keith Webber on Setting Specifications
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
3
Ivonescimab Breakthrough Designation Highlights Progress in BTC Treatment
4
Speed-to-IND Starts with Toxicology: A Rapid-Fire Q&A with Lonza
5